News Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy Publish Date December 14, 2021 Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.
News Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases Publish Date May 10, 2022 Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.